Sopharma Trading AD (XBUL:SFT) Total Liabilities : лв510 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Total Liabilities?

Sopharma Trading AD's Total Liabilities for the quarter that ended in Sep. 2023 was лв510 Mil.

Sopharma Trading AD's quarterly Total Liabilities increased from Mar. 2023 (лв491.85 Mil) to Jun. 2023 (лв503.08 Mil) and increased from Jun. 2023 (лв503.08 Mil) to Sep. 2023 (лв510.24 Mil).

Sopharma Trading AD's annual Total Liabilities declined from Dec. 2020 (лв539.59 Mil) to Dec. 2021 (лв497.96 Mil) and declined from Dec. 2021 (лв497.96 Mil) to Dec. 2022 (лв478.01 Mil).

Sopharma Trading AD Total Liabilities Historical Data

The historical data trend for Sopharma Trading AD's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Total Liabilities Chart

Sopharma Trading AD Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

348.35

408.24

539.59

497.96

478.01

Sopharma Trading AD Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Liabilities	Get a 7-Day Free Trial															488.15	478.01	491.85	503.08	510.24

Sopharma Trading AD Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sopharma Trading AD's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	379.03	+	(82.469	+	14.733
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1.777)
	=	478

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	572.554	-	94.545
	=	478

Sopharma Trading AD's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	424.552	+	(21.387	+	64.305
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	510

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	628.685	-	118.441
	=	510

Sopharma Trading AD Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma Trading AD (XBUL:SFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756

Website

http://www.sopharmatrading.bg

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines